Trademark: 87183580
Status Date
Tuesday, April 23, 2019
Filing Date
Monday, September 26, 2016
Published for Opposition
Tuesday, February 28, 2017
Abandoned Date
Monday, April 22, 2019
5 Pharmaceutical product, namely, radiolabelled pharmaceutical preparations that target neuroendocrine tumor cell surface receptors for the detection and localization of neuroendocrine tumors in cancer patients and for targeted diagnostic management of the neuroendocrine tumors in cancer patients
Apr 23, 2019
Abandonment Notice E-Mailed - After Publication
Apr 23, 2019
Abandonment - After Publication
Apr 22, 2019
Teas Express Abandonment Received
Feb 1, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 1, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 22, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 20, 2018
Extension 3 Granted
Sep 20, 2018
Extension 3 Filed
Sep 20, 2018
Teas Extension Received
Apr 18, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 16, 2018
Extension 2 Granted
Apr 16, 2018
Extension 2 Filed
Apr 16, 2018
Teas Extension Received
Aug 2, 2017
Notice Of Approval Of Extension Request E-Mailed
Jul 31, 2017
Extension 1 Granted
Jul 31, 2017
Extension 1 Filed
Jul 31, 2017
Teas Extension Received
Apr 25, 2017
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2017
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2017
Published For Opposition
Feb 8, 2017
Notification Of Notice Of Publication E-Mailed
Jan 17, 2017
Approved For Pub - Principal Register
Jan 17, 2017
Examiner's Amendment Entered
Jan 17, 2017
Notification Of Examiners Amendment E-Mailed
Jan 17, 2017
Examiners Amendment E-Mailed
Jan 17, 2017
Examiners Amendment -Written
Jan 2, 2017
Assigned To Examiner
Sep 29, 2016
New Application Office Supplied Data Entered In Tram
Sep 29, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
